FDL-169

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameFDL-169
Drug Alias NameFDL-169
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaAustraliaGermany +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFlatley Discovery Lab Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFlatley Discovery Lab Llc
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A